9amHealth

Overview

Virtual cardiometabolic care clinic covering obesity, diabetes, hypertension, and hyperlipidemia, working with employers and pharmaceutical manufacturers. Named an independent telehealth provider at the January 2024 launch of Eli Lilly's LillyDirect and partnered with Novo Nordisk for obesity care access via NovoCare.com.

Notable

Raised a $26M Series B led by Define Ventures (May 2026); also partnered with Mark Cuban Cost Plus Drugs on employer obesity care.

Key services

virtual specialist-led cardiometabolic care
GLP-1 access programs
employer pharmacy benefit programs
manufacturer channel partnerships

Subcategories

Condition Specific Telehealth
Cardiometabolic
Manufacturer Partnerships

Verified Reviews

No verified reviews yet — are you a customer of 9amHealth? Share your experience in a short, confidential interview.

Share your experience

Sources

https://www.prnewswire.com/news-releases/9amhealth-teams-up-with-novo-nordisk-to-expand-access-to-evidence-based-virtual-obesity-care-nationwide-302539741.html
https://www.prnewswire.com/news-releases/9amhealth-raises-26m-to-expand-into-chronic-conditions-driving-the-majority-of-employer-pharmacy-spend-302769972.html